DGCR11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.582200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.043200E-01
Normal-vs-Stage2
9.633600E-01
Normal-vs-Stage3
5.947000E-01
Normal-vs-Stage4
7.111200E-01
Stage1-vs-Stage2
9.178000E-01
Stage1-vs-Stage3
5.159600E-01
Stage1-vs-Stage4
8.298400E-01
Stage2-vs-Stage3
5.599200E-01
Stage2-vs-Stage4
7.468400E-01
Stage3-vs-Stage4
6.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.691000E-01
Normal-vs-AfricanAmerican
7.896600E-01
Normal-vs-Asian
7.110200E-01
Caucasian-vs-AfricanAmerican
7.359000E-01
Caucasian-vs-Asian
5.739600E-01
AfricanAmerican-vs-Asian
9.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.901800E-01
Normal-vs-Female
7.633400E-01
Male-vs-Female
3.476000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.531640E-01
Normal-vs-Age(41-60Yrs)
9.907200E-01
Normal-vs-Age(61-80Yrs)
9.315400E-01
Normal-vs-Age(81-100Yrs)
9.274600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.525800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.475600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.967600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.471400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.258000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.705000E-01
Normal-vs-Daily Drinker
7.914800E-01
Normal-vs-Weekly Drinker
4.152000E-01
Normal-vs-Occasional Drinker
8.823600E-01
Normal-vs-Social Drinker
9.724000E-01
Non Drinker-vs-Daily Drinker
5.825200E-01
Non Drinker-vs-Weekly Drinker
9.384100E-02
Non Drinker-vs-Occasional Drinker
8.916200E-01
Non Drinker-vs-Social Drinker
9.812400E-01
Daily Drinker-vs-Weekly Drinker
6.010200E-02
Daily Drinker-vs-Occasional Drinker
4.344400E-01
Daily Drinker-vs-Social Drinker
5.894000E-01
Weekly Drinker-vs-Occasional Drinker
1.400400E-01
Weekly Drinker-vs-Social Drinker
1.252420E-01
Occasional Drinker-vs-Social Drinker
8.566400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.481800E-01
Normal-vs-Grade 2
8.000400E-01
Normal-vs-Grade 3
8.817400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.822300E-03
Grade 1-vs-Grade 3
4.008500E-02
Grade 1-vs-Grade 4
8.481800E-01
Grade 2-vs-Grade 3
5.855200E-01
Grade 2-vs-Grade 4
8.000400E-01
Grade 3-vs-Grade 4
8.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.534800E-01
Normal-vs-NonDiabetic
8.064400E-01
Diabetic-vs-NonDiabetic
1.870440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.412600E-01
Normal-vs-NoPancreatitis
9.106600E-01
Pancreatitis-vs-NoPancreatitis
1.167040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.773000E-01
Normal-vs-N1
9.236200E-01
N0-vs-N1
7.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.239800E-01
Normal-vs-TP53-NonMutant
9.022600E-01
TP53-Mutant-vs-TP53-NonMutant
1.691960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
